Eli Lilly’s trial weight-loss drug reduces heart failure risk by 38%
Eli Lilly and Company’s Zepbound or trizepatide injection to treat obesity reduces the risk of heart failure, hospitalisation and cardiovascular death by 38%,.
Drugs
Health
Pharma
Drugs
Health
Pharma
Eli Lilly to buy Morphic for $3.2 b in cash to expand integrin therapies
Eli Lilly and Company will acquire biopharmaceutical firm, Morphic Holding Inc., for $3.2 billion in cash, giving it access to a molecule inhibitor.
Drugs
Health
Pharma
Viking Therapeutics’ weight-loss drug shows ‘positive’ results in early trials
US-based biotechnology company Viking Therapeutics Inc., reported “positive” results from its early-stage weight-loss oral drug and the pill showed mild to moderate side.
Drugs
Health
Pharma
Eli Lilly’s LillyDirect offers direct access to obesity medication
HQ team January 6, 2024: Eli Lilly, the pharmaceutical company will now be selling its weightless drug directly to the consumer via its.
Drugs
Health
Pharma
Eli Lilly’s drug gets second FDA nod for treating blood cancer in adults
HQ Team December 4, 2023: Eli Lilly and Company got a second accelerated approval from the Food and Drug Administration for its blood.
Drugs
Health
Pharma
Pfizer Inc., stops twice-daily oral obesity drug trial at mid-stage
HQ Team December 2, 2023: Pfizer Inc., has discontinued its clinical trials of the twice-daily oral weight-loss drug, danuglipron, after more than 50%.
Drugs
Medical
Pharma
Eli Lilly’s Zepbound outperforms Novo’s Wegovy in weight loss study
HQ team November 28, 2023: A recent comparative analysis of Eli Lilly and Novo Nordisk’s weight loss drugs on diabetes patients showed Eli.
Drugs
Health
Pharma
Lilly to build $2.5b plant in Germany to make diabetes, obesity devices
HQ Team November 18, 2023: Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5.
Drugs
Health
Pharma
US, UK regulators give green light to Eli Lilly’s weight-loss treatment
HQ Team November 9, 2023: Eli Lilly’s weight-loss injection Zepbound, to be taken along as a supplement with diet and exercise, got the.
Drugs
Health
Pharma
Eli Lilly late-stage trial drug for Crohn’s disease meets testing goals
HQ Team October 13, 2023: Eli Lilly and Company announced its experimental drug for treating severe Crohn’s disease met secondary targets in efficacy.